Related Experiment Video
Updated: Aug 18, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Purulent meningitis in children: outcome using a standard management regimen with chloramphenicol
1Department of Child Health, Faculty of Medicine, University of Papua New Guinea.
Insights
This study on childhood purulent meningitis found a 16.7% fatality rate satisfactory for a high-risk population. Early diagnosis, supportive care, and prophylactic phenobarbitone for infants are recommended to improve outcomes.
Area of Science:
- Pediatric infectious diseases
- Clinical microbiology
- Epidemiology
Background:
- Purulent meningitis poses a significant threat to children, particularly in high-risk populations.
- Standardized management protocols are crucial for improving patient outcomes.
Purpose of the Study:
- To evaluate the effectiveness of a standard management regimen for childhood purulent meningitis.
- To identify factors associated with mortality and morbidity in pediatric meningitis cases.
- To provide recommendations for optimizing treatment strategies.
Main Methods:
- A prospective study involving 108 children (2 weeks to 10 years) with purulent meningitis.
- Treatment primarily involved chloramphenicol, with initial intramuscular administration.
- Data collection included clinical presentation, treatment compliance, and outcomes.
Main Results:
- A case fatality rate of 16.7% was observed, considered satisfactory given the high-risk population.
- Good compliance with the chloramphenicol regimen was noted, but anticonvulsant use was suboptimal.
- Convulsions, coma on admission, and prolonged illness duration (>3 days) were significantly associated with increased mortality.
Conclusions:
- The current antibiotic policy appears effective, but improvements are needed in early diagnosis and supportive care.
- Prophylactic phenobarbitone is recommended for children under 2 years with meningitis.
- Preventing convulsions and enhancing early detection are key to reducing mortality and morbidity.
Abstract:
We report a prospective study of 108 children aged from 2 weeks to 10 years with purulent meningitis admitted to the children's wards of Port Moresby General Hospital, 105 of whom were treated with a standard management regimen using chloramphenicol (given intramuscularly initially) as the only antibiotic. The case fatality rate of 16.7% and the apparently low morbidity rate were felt to be very satisfactory in a high risk population. The medical officers' compliance with the standard antibiotic regimen was good, but was disappointing for the use of anticonvulsants. The presence of convulsions before admission or at any time in the illness, coma on admission, and a history of illness of more than 3 days duration prior to admission were strongly associated with death. We believe phenobarbitone should be given prophylactically to children less than 2 years of age who have meningitis. Further improvements in outcome are likely to be achieved not by changes in antibiotic policy but by improving early diagnosis and basic supportive care, and by preventing convulsions.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Rocky Mountain Spotted Fever
Bacterial Meningitis
Viral Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology